Pfizer Sues Philippines' UniLab For Infringing Lipitor Patent
This article was originally published in PharmAsia News
Executive Summary
Pfizer has filed a patent-infringement suit against United Laboratories in the Philippines. UniLab, a generics maker, is accused by Pfizer of violating its patent for anti-cholesterol drug Lipitor (atorvastatin) by distributing a generic ahead of the Philippine patent's expiration in 2012